Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

CAROPHARMA : revenue, balance sheet and financial ratios

CAROPHARMA is a French company founded 7 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in BLAIN (44130), this company of category PME has financial data available below. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - CAROPHARMA (SIREN 840933428)
Indicator 2025 2024
Revenue N/C N/C
Net income 0 € 0 €
EBITDA N/C N/C
Net margin N/C N/C

Revenue and income statement

In 2025, CAROPHARMA records a net loss of 0 €. This deficit will reduce equity on the balance sheet.

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 59%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 22%. The balance between equity and debt is satisfactory.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

59.379%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

21.924%

Solvency indicators evolution
CAROPHARMA

Sector positioning

Debt ratio
59.38 2025
2024
2025
Q1: 0.14
Med: 27.24
Q3: 146.28
Average

In 2025, the debt ratio of CAROPHARMA (59.38) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
21.92% 2025
2024
2025
Q1: 17.38%
Med: 54.75%
Q3: 87.41%
Average

In 2025, the financial autonomy of CAROPHARMA (21.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 43.82. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

43.823

Liquidity indicators evolution
CAROPHARMA

Sector positioning

Liquidity ratio
43.82 2025
2024
2025
Q1: 159.67
Med: 1116.63
Q3: 6512.12
Watch -53 pts over 2 years

In 2025, the liquidity ratio of CAROPHARMA (43.82) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positioning of CAROPHARMA in its sector

Comparison with sector Fonds de placement et entités financières similaires

Similar companies (Fonds de placement et entités financières similaires)

Compare CAROPHARMA with other companies in the same sector:

Frequently asked questions about CAROPHARMA

What is the revenue of CAROPHARMA ?

The revenue of CAROPHARMA is not publicly disclosed (confidential accounts filed with INPI).

Is CAROPHARMA profitable?

Profitability information is not publicly available.

Where is the headquarters of CAROPHARMA ?

The headquarters of CAROPHARMA is located in BLAIN (44130), in the department Loire-Atlantique.

Where to find the tax return of CAROPHARMA ?

The tax return of CAROPHARMA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does CAROPHARMA operate?

CAROPHARMA operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.